Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5768194 | 0.92 | SLC2A1 (0.87) | SLC2A1KCNH2 | |
| SCHEMBL6080284 | 0.88 | SLC2A1 (0.78) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL5744496 | 0.88 | SLC2A1 (0.79) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL6079904 | 0.88 | SLC2A1 (0.79) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL6079391 | 0.88 | SLC2A1 (0.79) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL5747702 | 0.85 | KCNH2 (0.81) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL5747089 | 0.84 | SLC2A1 (0.73) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL6079816 | 0.81 | SLC2A1 (0.70) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL6079820 | 0.81 | SLC2A1 (0.70) | SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL6079806 | 0.81 | SLC2A1 (0.70) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | claimed |
| EP-1578743-A4 | ANTIBACTERIAL AGENTS | GLAXO GROUP LTD (GB) | 2006-11-29 | — | — | EP | disclosed |
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | disclosed |
| EP-1578743-A2 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004058144-A2 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2004-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | NQO2, NRDC, IFNG | SLC2A1 4409/4885KCNH2 3365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.